ARCHIVES

Emory Executive Objects to Report On Merit review

This article is from The Cancer Letter archive.

Vol. 03 No. 29 | July 22, 1977

Download PDF Visit The Full Archive

Related Articles

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

NCI To Fund 22 Of 38 Clinical Investigator Applications, Five Of Them To Surgeons

June 1, 1984

Radiology Advocated As First Diagnostic Test After Hemoccult

April 25, 1986